TMCnet News

Research and Markets: Global Peritoneal Cancer Therapeutics Pipeline Review H2 2015
[January 14, 2016]

Research and Markets: Global Peritoneal Cancer Therapeutics Pipeline Review H2 2015


Research and Markets (http://www.researchandmarkets.com/research/xbd6ql/peritoneal_cancer) has announced the addition of the "Peritoneal Cancer - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Peritoneal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peritoneal Cancer and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Peritoneal Cancer Overview
  3. Therapeutics Development
  4. Pipeline Products for Peritoneal Cancer - Overview
  5. Pipeline Products for Peritoneal Cancer - Comparative Analysis
  6. Peritoneal Cancer - Therapeutics under Development by Companies
  7. Peritoneal Cancer - Therapeutics under Investigation by Universities/Institutes
  8. Peritoneal Cancer - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Peritoneal Cancer - Products under Development by Companies
  13. Peritoneal Cancer - Products under Investigation by Universities/Institutes
  14. Peritoneal Cancer - Companies Involved in Therapeutics Development



Companies Mentioned - Partial List

  • AbbVie Inc.
  • Acceleron Pharma, Inc.
  • Adaptimmune Limited
  • Advanced Accelerator Applications SA
  • Amgen Inc.
  • Array BioPharma Inc.
  • Astex Pharmaceuticals, Inc.
  • AstraZeneca Plc
  • Atara Biotherapeutics, Inc.
  • AVEO Pharmaceuticals, Inc.
  • Bayer AG
  • Beth Israel Deaconess Medical Center, Inc.
  • Bionomics Limited
  • Boehringer Ingelheim GmbH
  • Caladrius Biosciences, Inc.
  • Celldex Therapeutics, Inc.
  • Celsion Corporation
  • Cerulean Pharma, Inc.
  • Clovis Oncology, Inc.
  • Corcept Therapeutics Incorporated
  • Critical Outcome Technologies Inc.
  • CritiTech, Inc.
  • CTI (News - Alert) BioPharma Corp.
  • Dr. Reddy's Laboratories Limited
  • EirGenix Inc.
  • Eli Lilly and Company
  • Epirus Biopharmaceuticals, Inc.
  • Exelixis, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Galena Biopharma, Inc.

For more information visit http://www.researchandmarkets.com/research/xbd6ql/peritoneal_cancer



[ Back To TMCnet.com's Homepage ]